RANTES release contributes to the protective action of PACAP38 against sodium nitroprusside in cortical neurons

Neuropeptides

Volumn 43, Issue 4, 2009, Pages 315-320

  Sanchez, Alma ^a   Tripathy, Debjani ^a   Grammas, Paula ^a  

^a TEXAS TECH UNIVERSITY HEALTH SCIENCES CENTER   (United States)

Author keywords

Chemokine; Inflammation; MIP 1 ; Neuronal survival; Neuroprotection; PACAP; RANTES

Indexed keywords

CHEMOKINE; G PROTEIN COUPLED RECEPTOR; HYPOPHYSIS ADENYLATE CYCLASE ACTIVATING POLYPEPTIDE; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; NEUTRALIZING ANTIBODY; NITROPRUSSIDE SODIUM; RANTES;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; BRAIN CELL; CELL CULTURE; CELL SURVIVAL; CONTROLLED STUDY; CULTURE MEDIUM; ENDOTHELIUM CELL; FETUS; GLIA CELL; IMMUNOMODULATION; INCUBATION TIME; NERVE CELL NECROSIS; NERVE REGENERATION; NERVOUS SYSTEM DEVELOPMENT; NEUROPROTECTION; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN SECRETION; RAT; SIGNAL TRANSDUCTION;

ANIMALS; CELLS, CULTURED; CEREBRAL CORTEX; CHEMOKINE CCL3; CHEMOKINE CCL5; NEURONS; NEUROPROTECTIVE AGENTS; NITROPRUSSIDE; PITUITARY ADENYLATE CYCLASE-ACTIVATING POLYPEPTIDE; RATS;

EID: 67651005601     PISSN: 01434179     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.npep.2009.05.002     Document Type: Article

References (55)

1. Abad C., Gomariz R.P., and Waschek J.A. Neuropeptide mimetics and antagonists in the treatment of inflammatory disease: focus on VIP and PACAP. Curr. Top. Med. Chem. 6 (2006) 151-163
2. Arimura A. Perspectives on pituitary adenylate cyclase activating polypeptide (PACAP) in the neuroendocrine, endocrine, and nervous systems. Jpn. J. Physiol. 48 (1998) 301-331
3. Armstrong B.D., Abad C., Chhith S., Cheung-Lau G., Hajji O.E., Nobuta H., and Waschek J.A. Impaired nerve regeneration and enhanced neuroinflammatory response in mice lacking pituitary adenyl cyclase activating peptide. Neuroscience 151 (2008) 63-73
4. Balashov K.E., Rottman J.B., Weiner H.L., and Hancock W.W. CCR5(+) and CXCR3 (+) T cells are increased in multiple sclerosis and their ligands MIP-1alpha and IP-10 are expressed in demyelinating brain lesions. Proc. Natl. Acad. Sci. 12 (1999) 6873-6878
5. Baranowska-Bik A., Bik W., Wolinska-Witort E., Chmielowska M., Martynska L., and Baranowska B. Can PACAP-38 modulate immune and endocrine responses during lipopolysacchardie (LPS)-induced acute inflammation?. Ann. NY Acad. Sci. 1070 (2006) 156-160
6. Brenneman D.E., Hauser J.M., Spong C., and Phillips T.M. Chemokine release is associated with the protective action of PACAP-38 against HIV envelope protein neurotoxicity. Neuropeptides 36 (2002) 271-280
7. Carta M.G., Serra P., Ghiani A., Manca E., Hardoy M.C., Del Giacco G.S., Diaz G., Carpiniello B., and Manconi P.E. Chemokines and pro-inflammatory cytokines in Down's syndrome: an early marker for Alzheimer-type dementia?. Psychother. Psychosom. 71 (2002) 233-236
8. Cartier L., Hartley O., Dubois-Dauphin M., and Krause K.H. Chemokine receptors in the central nervous system: role in brain inflammation and neurodegenerative diseases. Brain Res. Brain Res. Rev. 48 (2005) 16-42
9. Cauvin A., Robberecht P., De Neef P., Gourlet P., Vandermeers A., Vandermeers-Piret M.C., and Christophe J. Properties and distribution of receptors for pituitary adenylate cyclase activating peptide (PACAP) in rat brain and spinal cord. Regul. Pept. 35 (1991) 161-173
10. Chen Y., Samal B., Hamelink C.R., Xiang C.C., Chen Y., Chen M., Vaudry D., Brownstein M.J., Hallenbeck J.M., and Eiden L.E. Neuroprotection by endogenous and exogenous PACAP following stroke. Regul. Pept. 137 (2006) 4-19
11. Conroy S.M., Nguyen V., Quina L.A., Blakely-Gonzales P., Ur C., Netzeband J.G., Prieto A.L., and Gruol D.L. Interleukin-6 produces neuronal loss in developing cerebellar granule neuron cultures. J. Neuroimmunol. 155 (2004) 43-54
12. D'Agata V., Cavallaro S., Stivala F., and Canonico P.L. Tissue-specific and developmental expression of pituitary adenylate cyclase-activating polypeptide (PACAP) receptors in rat brain. Eur. J. Neurosci. 8 (1996) 310-318
13. Dejda A., Sokolowska P., and Nowak J.Z. Neuroprotective potential of three neuropeptides PACAP, VIP and PHI. Pharmacol. Rep. 57 (2005) 307-320
14. Dejda A., Jolivel V., Bourgault S., Seaborn T., Fournier A., Vaudry H., and Vaudry D. Inhibitory effect of PACAP on caspase activity in neuronal apoptosis: a better understanding towards therapeutic applications in neurodegenerative diseases. J. Mol. Neurosci. 36 (2008) 26-37
15. Eiden L.E., Samal B., Gerdin M.J., Mustafa T., Vaudry D., and Stroth N. Discovery of pituitary adenylate cyclase-activating polypeptide-regulated genes through microarray analyses in cell culture and in vivo. Ann. NY Acad. Sci. 1144 (2008) 6-20
16. Eugenin E.A., D'Aversa T.G., Lopez L., Calderon T.M., and Berman J.W. MCP-1 (CCL2) protects human neurons and astrocytes from NMDA or HIV-tat-induced apoptosis. J. Neurochem. 85 (2003) 1299-1311
17. Fahrenkrug J. PACAP - a multifaceted neuropeptide. Chronobiol. Int. 23 (2006) 53-61
18. Gamo K., Kiryu-Seo S., Konishi H., Aoki S., Matsushima K., Wada K., and Kiyama H. G-protein-coupled receptor screen reveals a role for chemokine receptor CCR5 in suppressing microglial neurotoxicity. J. Neurosci. 28 (2008) 11980-11988
19. Gomariz R.P., Juarranz Y., Abad C., Arranz A., Leceta J., and Martinez C. VIP-PACAP system in immunity: new insights for multitarget therapy. Ann. NY Acad. Sci. 1070 (2006) 51-74
20. Grammas P., Moore P., and Weigel P.H. Microvessels from Alzheimer's disease brains kill neurons in vitro. Am. J. Pathol. 154 (1999) 337-342
21. Heneka M.T., and O'Banion M.K. Inflammatory processes in Alzheimer's disease. J. Neuroimmunol. 184 (2007) 69-91
22. Huang D., Han Y., Rani M.R., Glabinski A., Trebst C., Sorensen T., Tani M., Wang J., Chien P., O'Bryan S., Bielecki B., Zhou Z.L., Majumder S., and Ransohoff R.M. Chemokines and chemokine receptors in inflammation of the nervous system: manifold roles and exquisite regulation. Immunol. Rev. 177 (2000) 52-67
23. 2+ mobilization and inositol trisphosphate (IP3) formation in cells transfected with G protein-coupled receptor 75. Br. J. Pharmacol. 149 (2006) 490-497
24. Jordan-Sciutto K.L., Murray Fenner B.A., Wiley C.A., and Achim C.L. Response of cell cycle proteins to neurotrophic factor and chemokine stimulation in human microglia. Exp. Neurol. 167 (2001) 205-214
25. Lue L.F., Rydel R., Brigham E.F., Yang L.B., Hampel H., Murphy Jr. G.M., Brachova L., Yan S.D., Walker D.G., Shen Y., and Rogers J. Inflammatory repertoire of Alzheimer's disease and nondemented elderly microglia in vitro. Glia 35 (2001) 72-79
26. McGeer P.L., Rogers J., and McGeer E.G. Inflammation, anti-inflammatory agents and Alzheimer disease: the last 12 years. J. Alzheimer's Dis. 9 (2006) 271-276
27. Mines M.M., Ding Y., and Fan G.H. The many roles of chemokine receptors in neurodegenerative disorders: emerging new therapeutical strategies. Curr. Med. Chem. 14 (2007) 2456-2470
28. Ohtaki H., Nakamachi T., Dohi K., Aizawa Y., Takaki A., Hodoyama K., Yofu S., Hashimoto H., Shintani N., Baba A., Kopf M., Iwakura Y., Matsuda K., Arimura A., and Shioda S. Pituitary adenylate cyclase-activating polypeptide (PACAP) decreases ischemic neuronal cell death in association with IL-6. Proc. Natl. Acad. Sci. USA 103 (2006) 7488-7493
29. Ohtaki H., Nakamachi T., Dohi K., and Shioda S. Role of PACAP in ischemic neural death. J. Mol. Neurosci. 36 (2008) 16-25
30. Onoue S., Endo K., Ohshima K., Yajima T., and Kashimoto K. The neuropeptide PACAP attenuates beta-amyloid (1-42)-induced toxicity in PC12 cells. Peptides 23 (2002) 1471-1478
31. Pattarini R., Smeyne R.J., and Morgan J.I. Temporal mRNA profiles of inflammatory mediators in the murine 1-methyl-4-phenyl-1,2,3,6-tetrahydropyrimidine model of Parkinson's disease. Neuroscience 145 (2007) 654-658
32. Pease J.E. Tails of the unexpected - an atypical receptor for the chemokine RANTES/CCL5 expressed in brain. Br. J. Pharmacol. 149 (2006) 460-462
33. Peng Y.P., Qiu Y.H., Lu J.H., and Wang J.J. Interleukin-6 protects cultured cerebellar granule neurons against glutamate-induced neurotoxicity. Neurosci. Lett. 374 (2005) 192-196
34. Pozo D., Guerrero J.M., and Calvo J.R. Vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide inhibit LPS-stimulated MIP-1alpha production and mRNA expression. Cytokine 18 (2002) 35-42
35. Reimann-Philipp U., Ovase R., Weigel P.H., and Grammas P. Mechanisms of cell death in primary cortical neurons and PC12 cells. J. Neurosci. Res. 64 (2001) 654-660
36. Rostene W., and Buckingham J.C. Chemokines as modulators of neuroendocrine functions. J. Mol. Endocrinol. 38 (2007) 351-353
37. Sanchez A., Chiriva-Internati M., and Grammas P. Transduction of PACAP38 protects primary cortical neurons from neurotoxic injury. Neurosci. Lett. 448 (2008) 52-55
38. Sanchez A.C., Rao H.V., and Grammas P. PACAP38 protects rat cortical neurons against the neurotoxicity evoked by sodium nitroprusside and thrombin. Regul. Pept. 152 (2009) 33-40
39. Sastre M., Klockgether T., and Heneka M.T. Contribution of inflammatory processes to Alzheimer's disease: molecular mechanisms. Int. J. Dev. Neurosci. 24 (2006) 167-176
40. Shintani N., Suetake S., Hashimoto H., Koga K., Kasai A., Kawaguchi C., Morita Y., Hirose M., Sakai Y., Tomimoto S., Matsuda T., and Baba A. Neuroprotective action of endogenous PACAP in cultured rat cortical neurons. Regul. Pept. 126 (2005) 123-128
41. Shioda S., Ohtaki H., Nakamachi T., Dohi K., Watanabe J., Nakajo S., Arata S., Kitamura S., Okuda H., Takenoya F., and Kitamura Y. Pleiotropic functions of PACAP in the CNS: neuroprotection and neurodevelopment. Ann. NY Acad. Sci. 1070 (2006) 550-560
42. Somogyvari-Vigh A., and Reglodi D. Pituitary adenylate cyclase activating polypeptide: a potential neuroprotective peptide. Curr. Pharm. Des. 10 (2004) 2861-2889
43. Staines D.R. Is Parkinson's disease and autoimmune disorder of endogenous vasoactive neuropeptides?. Med. Hypotheses 69 (2007) 1208-1211
44. Staines D.R. Are multiple sclerosis and amyotrophic lateral sclerosis autoimmune disorders of endogenous vasoactive neuropeptides?. Med. Hypotheses 70 (2008) 413-418
45. Suk K., Park J.H., and Lee W.H. Neuropeptide PACAP inhibits hypoxic activation of brain microglia: a protective mechanism against microglial neurotoxicity in ischemia. Brain Res. 1026 (2004) 151-156
46. Tripathy D., and Grammas P. Acetaminophen inhibits neuronal inflammation and protects neurons from oxidative stress. J. Neuroinflammation 6 (2009) 10
47. Tripathy D., Thirumangalakudi L., and Grammas P. RANTES upregulation in the Alzheimer's disease brain: a possible neuroprotective role. Neurobiol. Aging 25 (2008) [Epub ahead of print]
48. Tsakiri N., Kimber I., Rothwell N.J., and Pinteaux E. Mechanisms of interleukin-6 synthesis and release induced by interleukin-1 and cell depolarization in neurons. Mol. Cell Neurosci. 37 (2008) 110-118
49. Valerio A., Ferrario M., Martinez F.O., Locati M., Ghisi V., Bresciani L.G., Mantovani A., and Spano P. Gene expression profile activated by the chemokine CCL5/RANTES in human neuronal cells. J. Neurosci. Res. 78 (2004) 371-382
50. Vaudry D., Pamantung T.F., Basille M., Rousselle C., Fournier A., Vaudry H., Beauvillain J.C., and Gonzalez B.J. PACAP protects cerebellar granule neurons against oxidative stress-induced apoptosis. Eur. J. Neurosci. 15 (2002) 1451-1460
51. Wang G., Qi C., Fan G.H., Zhou H.Y., and Chen S.D. PACAP protects neuronal differentiated PC12 cells against the neurotoxicity induced by a mitochondrial complex I inhibitor, rotenone. FEBS Lett. 579 (2005) 4005-4011
52. Wang H.K., Park U.J., Kim S.Y., Lee H.H., Kim S.U., Gwag B.J., and Lee Y.B. Free radical production in CA1 neurons induces MIP-1alpha expression, microglia recruitment, and delayed neuronal death after transient forebrain ischemia. J. Neurosci. 28 (2008) 1721-1727
53. Wang X.Q., Peng Y.P., Lu J.H., Cao B.B., and Qiu Y.H. Neuroprotection of interleukin-6 against NMDA attack and its signal transduction by JAK and MAPK. Neurosci. Lett. 450 (2009) 122-126
54. Waschek J.A. Multiple actions of pituitary adenylyl cyclase activating peptide in nervous system development and regeneration. Dev. Neurosci. 24 (2002) 14-23
55. Zhou C.J., Shioda S., Yada T., Inagaki N., Pleasure S.J., and Kikuyama S. PACAP and its receptors exert pleiotropic effects in the nervous system by activating multiple signaling pathways. Curr. Protein Pept. Sci. 3 (2002) 423-439